Kim D-H, Park H-J, Lim S, Lee H-G, Choi JO, Oh JH, et al. Regulation of chitinase-3-like-1 in T cell elicites Th1 nad cytotoxic responses to inhibit lung metastasis. Nat Commun 2018; 9(503): 1-14.
Roopavathy AS, Vigneshwari R, Jayapradha R. Chitinase production and applicatons. J Chem Pharm Res 2015; 7(5): 924-31.
Rameshthangam P, Solairaj D, Arunachalam G, Ramasamy P. Chitin and chitinases: Biomedical and environmental applications of chitin and its derivatives. J Enz 2018; 1(1): 20-43.
Sunazuka T, Hirose T, Omura S. Rapid Identification via in situ click chemistry of a novel chitinase inhibitor. J Synt Org Chem 2016; 74(11): 62-8.
Sakuda S. Studies on the chitinase inhibitors, allosamidins Chitin enzymology 1996. 2.
Mazur M, Koralewski R, Borek B, et al. Substituted amino triazoles useful as human chitinase inhibitors.US10208020 (2019).
Anderberg J, Gray J, McPherson P, Nakamura K, Kampf JP. Methods for evaluating renal injury and renal failure using urine levels of chitinase - 3 - like protein 1. US20190120858 (2019).
Bernard D, Berville MD. Cosmetic use of chitinase - type proteins.US9926587 (2018).
Richard L, Steven VD. Chitinase administration to the airway to treat inflammation and age-related pulmonary fibrosis.WO2018191379 (2018).
Sanfilippo S, Posteraro B, Sanguinetti M, et al. New macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chtinase inhibitors. US20160137617 (2016).
Golebiowski AA, Koralewski R, Czestkowski W, et al. Matyszewski, K., Olejniczak, S., Olczak, J., Beckett, P. Substituted amino triazoles useful as human chitinase inhibitors. US2016176843 (2016)
Golebiowski AA, Koralewski R, Czestkowski W, et al. Matyszewski, K., Olejniczak, S., Olczak, J., Beckett, P. Substituted amino triazoles useful as acidic mammallian chitinase inhibitors. US20160368894 (2016).
Corman MM, Gollebiowski A, Beckett RP, Mazur M, Olezniczak S. Substituted amino triazoles, and methods using same. WO2015095701 (2015).
Reed JL, White W, Coyle A, et al. C/CLPantagonists and methods of use there of. US20110059100 (2011).
Vora KA, Demartino JA, Mudgett JS, Poster J, Wolfe G. Novel human acidic mammalian chitinase and use thereof.US20090191552 (2009).
Reed JL, White W, Coyle A, Kozhich A, Elias J. C/CLP antagonists and methods of use thereof. WO2007027748 (2007).
Olafur BE, Jon ME, Johannes G, Finnbogi T. Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins. WO2006054319 (2006).
Maximillian TF. Inhibitors of acidic mammalian chitinase as asthma therapeutics WO2004092404 (2004).
Elias J, Zhu Z. Methods, compositions and kits relating to chitinases and chitin like molecules and inflammatory disease. WO03009808 (2003).
Harman GE, Broadway RM, Tronsmom A, Lorito M, Hayes CK, Pietr AD. Purified chitinases and use thereof. US6251390 (2001).
Mack I, Hector A, Ballbach M. Kohlhäuf lJ, FuchsKJ, Weber A, etal.The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases. Mol Cell Pediatr 2015; 2(3): 1-8.
Iqbal RK, Anwar FN. Chitinases potential as biocontrol. Biomed J Sci Tech Res 2019; 14(5): 10994-1001.
Gomma EZ. Chitinase production by Bacillus thuringiensis and Bacillus licheniformis: Their potential in antifungal biocontrol. J Microbiol 2012; 50: 103-11.